Serum adipocyte fatty acid-binding protein levels in patients with critical illness are associated with insulin resistance and predict mortality

Critical Care

Volumn 17, Issue 1, 2013, Pages

  Huang, Chi Lun ^a,b,c   Wu, Yen Wen ^b,d,e   Hsieh, Ai Ru ^f   Hung, Yu Hsuan ^c   Chen, Wen Jone ^b   Yang, Wei Shiung ^b,c  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; FATTY ACID BINDING PROTEIN 4; GLUCOSE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION 2 SCORE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INSULIN RESISTANCE; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SURVIVAL RATE;

EID: 84873036785     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12498     Document Type: Article

References (34)

1. Losser MR, Damoisel C, Payen D. Bench-to bedside review: glucose and stress conditions in the intensive care units. Crit Care 2010, 14:231. 10.1186/cc9100, 2945096, 20727232.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778. 10.1016/S0140-6736(99)08415-9, 10711923.
3. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004, 56:1058-1062. 10.1097/01.TA.0000123267.39011.9F, 15179246.
4. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-2432. 10.1161/hs1001.096194, 11588337.
5. Mowery NT, May AK, Collier BC, Dossett LA, Gunter OL, Dortch MJ, Diaz JJ. Glucose metabolism, not obesity, predicts mortality in critically ill surgical patients. Am Surg 2010, 76:1377-1383.
6. Krinsley J, Preiser JC. Intensive insulin therapy to control hyperglycemia in the critically ill: a look back at the evidence shapes the challenges ahead. Crit Care 2010, 14:330. 10.1186/cc9275, 3220034, 21143774.
7. Deng Y, Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010, 1212:E1-19. 3075414, 21276002.
8. Fève B, Bastard JP, Vidal H. Relationship between obesity, inflammation and insulin resistance: new concepts. C R Biol 2006, 329:587-597. Article in French, 10.1016/j.crvi.2006.03.020, 16860277.
9. Andreelli F, Jacquier D, Troy S. Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care 2006, 9:124-130. 10.1097/01.mco.0000214571.97933.0a, 16477177.
10. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 2008, 7:489-503. 10.1038/nrd2589, 2821027, 18511927.
11. Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao H, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 2008, 118:2640-2650. 2423863, 18551191.
12. Hui X, Li H, Zhou Z, Lam KS, Xiao Y, Wu D, Ding K, Wang Y, Vanhoutte PM, Xu A. Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J Biol Chem 2010, 285:10273-10280. 10.1074/jbc.M109.097907, 2856232, 20145251.
13. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS. Adipocyte fatty acid binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006, 52:405-413. 10.1373/clinchem.2005.062463, 16423904.
14. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007, 115:1537-1543. 10.1161/CIRCULATIONAHA.106.647503, 17389279.
15. Toruner F, Altinova AE, Akturk M, Kaya M, Arslan E, Bukan N, Kan E, Yetkin I, Arslan M. The relationship between adipocyte fatty acid binding protein-4, retinol binding protein-4 levels and early diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 2011, 91:203-207. 10.1016/j.diabres.2010.11.011, 21176857.
16. Kim YC, Cho YK, Lee WY, Kim HJ, Park JH, Park DI, Sohn CI, Jeon WK, Kim BI, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Ryu SH. Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. J Nutr Biochem 2011, 22:289-292. 10.1016/j.jnutbio.2010.02.007, 20579864.
17. Durovcová V, Marek J, Hána V, Matoulek M, Zikán V, Haluzíková D, Kaválková P, Lacinová Z, Kršek M, Haluzík M. Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing's syndrome. Physiol Res 2010, 59:963-971.
18. Wang J, Tang J, Wang B, Song J, Liu J, Wei Z, Zhang F, Ma X, Cao Y. FABP4: a novel candidate gene for polycystic ovary syndrome. Endocrine 2009, 36:392-396. 10.1007/s12020-009-9228-5, 19844814.
19. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
20. Koch A, Weiskirchen R, Sanson E, Zimmermann HW, Voigt S, Dückers H, Trautwein C, Tacke F. Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation. Crit Care 2010, 14:R179. 10.1186/cc9285, 3219283, 20932285.
21. Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009, 13:R95. 10.1186/cc7925, 2717467, 19545363.
22. Koch A, Weiskirchen R, Zimmermann HW, Sanson E, Trautwein C, Tacke F. Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators Inflamm 2010, 2010:pii: 473540.
23. Koch A, Sanson E, Voigt S, Helm A, Trautwein C, Tacke F. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care 2011, 26:166-174. 10.1016/j.jcrc.2010.07.015, 20869198.
24. Furuhashi M, Ishimura S, Ota H, Miura T. Lipid chaperones and metabolic inflammation. Int J Inflam 2011, 2011:642612. 3206330, 22121495.
25. Jernås M, Olsson B, Sjöholm K, Sjögren A, Rudemo M, Nellgård B, Carlsson LM, Sjöström CD. Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness. Metabolism 2009, 58:102-108. 10.1016/j.metabol.2008.08.012, 19059537.
26. Han Q, Yeung SC, Ip MS, Mak JC. Effects of intermittent hypoxia on A-/E-FABP expression in human aortic endothelial cells. Int J Cardiol 2010, 145:396-398. 10.1016/j.ijcard.2010.04.027, 20452069.
27. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991, 24:195-201. 10.1016/0009-9120(91)90571-U, 2040092.
28. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005, 352:15-35. 10.1016/j.cccn.2004.09.001, 15653098.
29. Zhang ZC, Dai HW, Yu YH, Yang JD, Hu CB. Usefulness of heart-type fatty acid-binding protein in patients with severe sepsis. J Crit Care 2012, 27:415. e13-8.
30. Doi K, Noiri E, Maeda-Mamiya R, Ishii T, Negishi K, Hamasaki Y, Fujita T, Yahagi N, Koide H, Sugaya T, Nakamura T. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med 2010, 38:2037-2042.
31. Aragonès G, Saavedra P, Heras M, Cabré A, Girona J, Masana L. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol 2012, 11:72. 10.1186/1475-2840-11-72, 3503556, 22709426.
32. Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, Schunck WH, Ehrhart-Bornstein M, Bornstein SR, Morano I. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009, 105:326-334. 10.1161/CIRCRESAHA.109.200501, 19608978.
33. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol 2005, 25:1220-1224. 10.1161/01.ATV.0000159163.52632.1b, 15705927.
34. Wu YW, Kao HL, Huang CL, Chen MF, Lin LY, Wang YC, Lin YH, Lin HJ, Tzen KY, Yen RF, Chi YC, Huang PJ, Yang WS. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Eur J Nucl Med Mol Imaging 2012, 39:399-407. 10.1007/s00259-011-1994-7, 22109668.